Population genetics and drug resistance markers: an essential for malaria surveillance in Pakistan
- PMID: 24304992
Population genetics and drug resistance markers: an essential for malaria surveillance in Pakistan
Abstract
Plasmodium (P.) vivax is the prevalent malarial species accounting for 70% of malaria cases in Pakistan. However, baseline epidemiological data on P. vivax population structure and drug resistance are lacking from Pakistan. For population structure studies, molecular genetic markers, circumsporozoite protein (csp) and merozoite surface protein-1 (msp-1) are considered useful as these play an important role in P. vivax survival under immune and environmental pressure. Furthermore, these genes have also been identified as suitable candidates for vaccine development. While efforts for effective vaccine are underway, anti-malarial agents remain the mainstay for control. Evidence of resistance against commonly used anti-malarial agents, particularly Sulphadoxine-Pyrimethamine (SP) is threatening to make this form of control defunct. Therefore, studies on drug resistance are necessary so that anti-malarial treatment strategies can be structured and implemented accordingly by the Malaria Control Program, Pakistan. This review aims to provide information on genetic markers of P. vivax population structure and drug resistance and comment on their usefulness in molecular surveillance and control.
Similar articles
-
Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.Antimicrob Agents Chemother. 2008 Dec;52(12):4233-40. doi: 10.1128/AAC.00578-08. Epub 2008 Sep 22. Antimicrob Agents Chemother. 2008. PMID: 18809933 Free PMC article.
-
Plasmodium vivax: prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax clinical isolates from Pakistan.Exp Parasitol. 2011 Jan;127(1):167-72. doi: 10.1016/j.exppara.2010.07.011. Epub 2010 Jul 23. Exp Parasitol. 2011. PMID: 20655913
-
High frequency of genetic diversity of Plasmodium vivax field isolates in Myanmar.Acta Trop. 2009 Jan;109(1):30-6. doi: 10.1016/j.actatropica.2008.09.006. Epub 2008 Sep 18. Acta Trop. 2009. PMID: 18851938
-
[The current status of the resistance of malaria pathogens to antimalarials].Med Parazitol (Mosk). 2014 Jul-Sep;(3):51-7. Med Parazitol (Mosk). 2014. PMID: 25286554 Review. Russian.
-
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.Curr Opin Infect Dis. 2009 Oct;22(5):430-5. doi: 10.1097/QCO.0b013e32832f14c1. Curr Opin Infect Dis. 2009. PMID: 19571748 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials